<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03376971</url>
  </required_header>
  <id_info>
    <org_study_id>1706540415</org_study_id>
    <secondary_id>NCI-2017-02088</secondary_id>
    <secondary_id>1706540415</secondary_id>
    <secondary_id>P30CA023074</secondary_id>
    <nct_id>NCT03376971</nct_id>
  </id_info>
  <brief_title>Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy</brief_title>
  <official_title>Real-Time Optical Biopsy for Improved Lung Cancer Diagnosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arizona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Arizona</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot early phase I trial studies how well real-time optical biopsy works in improving
      lung cancer diagnosis in patients undergoing lung biopsy. Real-time optical biopsy using
      confocal microscopy may improve the ability of physicians to diagnose lung cancer and
      accurately differentiate cancerous and benign lesions found during computed tomography
      screening.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:

      I. Show that it is possible to distinguish lung cancer from benign lesions in ex vivo tissue
      samples using optical microscopy.

      II. Test a proof-of-concept endoscopic instrument for imaging through a biopsy needle under
      computed tomography (CT) guidance on ex vivo tissue samples.

      OUTLINE:

      Patients undergo extraction of up to 3 additional lung biopsies from target lesions that are
      at least 2-3 cm in diameter using the 19 gauge SuperCore biopsy needle or the 20 gauge Rotax
      needle. The extracted tissue is imaged via confocal fluorescence microscopy using a variety
      of fluorescent contrast agents, such as, fluorescein sodium, methylene blue, or indocyanine
      green and then undergo hematoxylin and eosin processing.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 26, 2017</start_date>
  <completion_date type="Anticipated">November 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnosis of ex vivo tissue samples for lung cancer or benign lesions using optical microscopy</measure>
    <time_frame>At the time of biopsy</time_frame>
    <description>The aim is to show that it is possible to distinguish lung cancer from benign lesions in ex vivo tissue samples using optical microscopy.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Imaging of ex vivo tissue samples using an endoscopic instrument</measure>
    <time_frame>At the time of biopsy</time_frame>
    <description>A proof-of-concept endoscopic instrument will be tested for imaging through a biopsy needle under computed tomography guidance on ex vivo tissue samples.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Lesion</condition>
  <condition>Lung Cancer</condition>
  <condition>Diagnoses Disease</condition>
  <arm_group>
    <arm_group_label>Diagnostic (lung biopsy)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo extraction of up to 3 additional lung biopsies from target lesions that are at least 2-3 cm in diameter using the 19 gauge SuperCore biopsy needle or the 20 gauge Rotax needle. The extracted tissue is imaged via confocal fluorescence microscopy using a variety of fluorescent contrast agents, such as fluorescein sodium, methylene blue, indocyanine green and then undergo hematoxylin and eosin processing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biopsy</intervention_name>
    <description>Undergo lung biopsy</description>
    <arm_group_label>Diagnostic (lung biopsy)</arm_group_label>
    <other_name>Bx</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Laboratory Biomarker Analysis</intervention_name>
    <description>Correlative studies</description>
    <arm_group_label>Diagnostic (lung biopsy)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants will be drawn from the pool of patients who have suspicious lesions
             identified on CT and who are already scheduled for a lung biopsy procedure with Dr.
             Hennemeyer or one of his colleagues

          -  Patients will be asked to consent to 2 to 3 extra biopsy samples to be used for this
             research project

        Exclusion Criteria:

        - Excluded from this study will be prisoners, pregnant women, patients with a
        contraindication for additional lung biopsies, and patients who cannot give informed
        consent (language barrier, cognitive impairment, etc.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles Hennemeyer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Arizona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrew Rouse, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Arizona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gregory Woodhead, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Arizona</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charles Hennemeyer, MD</last_name>
    <phone>520-626-1957</phone>
    <email>cth@radiology.arizona.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andrew Rouse, PhD</last_name>
    <phone>520-626-5894</phone>
    <email>rouse@u.arizona.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Hennemeyer, MD</last_name>
      <phone>520-626-1957</phone>
      <email>cth@radiology.arizona.edu</email>
    </contact>
    <contact_backup>
      <last_name>Andrew Rouse, PhD</last_name>
      <phone>520-626-5894</phone>
      <email>rouse@u.arizona.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Charles Hennemeyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew Rouse, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gregory Woodhead, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2017</study_first_submitted>
  <study_first_submitted_qc>December 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2017</study_first_posted>
  <last_update_submitted>December 13, 2017</last_update_submitted>
  <last_update_submitted_qc>December 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lesion</keyword>
  <keyword>Lung</keyword>
  <keyword>Cancer</keyword>
  <keyword>Diagnosis</keyword>
  <keyword>Optical Biopsy</keyword>
  <keyword>Biopsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

